Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 22Triple Negative Breast Neoplasms 9Lung Neoplasms 8Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Adenocarcinoma 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Resectable Pancreatic Cancer 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Neoplasms, Basal Cell 1Metastatic Pancreatic Ductal Adenocarcinoma 1Metastatic Adenocarcinoma of the Pancreas 1

Interventions

X-Rays 8Specimen Handling 8Cyclophosphamide 8Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6fludarabine 5cabozantinib 5Gemcitabine 5Biopsy 5Nuclear Medicine Department, Hospital 4Methotrexate 4Doxorubicin 4fludarabine phosphate 3Ifosfamide 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2olaparib 2mifamurtide 2larotrectinib 2ivosidenib 2irinotecan sucrosofate 2ensartinib 2atezolizumab 2Vincristine 2Temozolomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Albumin-Bound Paclitaxel × 90 days × Clear all
NCT02945800 2026-04-02

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
59 enrolled 11 charts
Sarcoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡